Wanbury Limited (NSE:WANBURY)
India · Delayed Price · Currency is INR 226.20
-6.90 (-2.96%)
Sep 24, 2026, 3:29 PM IST
Wanbury Market Cap
Wanbury has a market cap or net worth of 8.15 billion as of September 23, 2026. Its market cap has decreased by -6.33% in one year.
Market Cap
8.15B
Enterprise Value
10.31B
Revenue
6.53B
Ranking
n/a
PE Ratio
14.58
Stock Price
226.20
ChartMarket Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 8.15B, an increase of 360.81%. That is a compound annual growth rate of 7.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 8.15B | 2.78% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 25.87B |
| Indoco Remedies | 23.18B |
| Windlas Biotech | 22.23B |
| Beta Drugs | 22.18B |
| Anlon Healthcare | 15.78B |
| Jagsonpal Pharmaceuticals | 14.88B |
| Sigachi Industries | 11.98B |
| Bafna Pharmaceuticals | 7.96B |